ICON PLC
ICLR
Detailliertes Diagramm anzeigen
180.010USD
+2.170+1.22%
Handelsschluss 09/03, 16:00（ET）Kurse um 15 Minuten verzögert
14.00BMarktkapitalisierung
17.63KGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
+1.22%
5 Tage
+4.80%
1 Monat
+8.15%
6 Monate
-5.27%
Seit Jahresbeginn
-14.16%
1 Jahr
-44.11%
Detailliertes Diagramm anzeigen
TradingKey Aktienbewertung
Währung: USD Aktualisiert：2025-09-02Wichtige Einblicke
Die Fundamentaldaten des Unternehmens sind relativ gesund. Seine Bewertung wird als unterbewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. In den letzten 30 Tagen haben mehrere Analysten die Aktie mit einer Kaufen bewertet. Trotz einer durchschnittlichen Aktienmarktperformance zeigt das Unternehmen starke Fundamentaldaten und technische Indikatoren. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
Aktienbewertung
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
19
Analysten
Kaufen
Aktuelles Rating
217.067
Kursziel
+21.99%
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
Unternehmens-Highlights
HöhepunkteRisiko
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
high_profit_growth
high_profit_growth_desc%!(EXTRA string=56.63)
valuation_overestimated
valuation_overestimated_desc%!(EXTRA string=PE, string=18.20)
institutional_decreasing_position
institutional_decreasing_position_desc%!(EXTRA string=74.28M, string=13.23%)
institutional_hold%!(EXTRA string=Ruane Cunniff)
institutional_hold_desc%!(EXTRA string=Ruane Cunniff, string=1.71M)
activity_decrease
activity_decrease_desc%!(EXTRA string=0.06)
Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Keine Daten
Gesamteinnahmen
Keine Daten
Unternehmen
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
BörsenkürzelICLR
UnternehmenICON PLC
CEODr. Stephen (Steve) Cutler, Ph.D.
Websitehttps://www.iconplc.com/
Verwandte Finanzinstrumente
+2.21%
+6.16%
+1.27%
+0.47%
-1.24%
-0.20%
-1.34%
+1.67%
-2.62%
+0.43%
-0.45%
-0.59%
-0.19%
+5.22%
+2.62%
-2.93%
0.00%
-0.15%
+0.64%
+0.61%
